adeno-associated virus vector based RHO gene therapy (Alia Therapeutics/University of Trento)

N/A

Report date: 2025/06/11 10:41:40

Base Information

Drug Nameadeno-associated virus vector based RHO gene therapy (Alia Therapeutics/University of Trento)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionRhodopsin inhibitors
TargetsRhodopsin
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Trento
China Registration ClassN/A

Develop Information

Active CompaniesAlia Therapeutics Srl
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A